PTPA and cancer: Our previous studies demonstrated that sustained activation of the JNK and NF-κB pathways, induced by PP2A inhibition, was responsible for the growth inhibition of cantharidin, indicating that activation of these kinase pathways was not always facilitating cancer progress.